RLAY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Relay Therapeutics (RLAY) Earnings Date & Reports

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RLAY is expected to report earnings to rise 14.58% to -51 cents per share on May 01

Relay Therapeutics RLAY Stock Earnings Reports

Q1'25

Est.

$-0.52

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.12

The last earnings report on February 26 showed earnings per share of -44 cents, beating the estimate of -56 cents. With 805.15K shares outstanding, the current market capitalization sits at 496.70M.

View a ticker or compare two or three

Compare

RLAY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RLAY
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RLAY (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

399 Binney Street

Phone

+1 617 370-8837

Employees

323

Web

https://www.relaytx.com